Last week, we reported on a SEC filing showing that Bellevue online advertising company AudienceScience had raised $15 million of a $20 million round. And today the company issued a press release confirming that it raised $20 million from existing investors Mohr, Davidow Ventures, Mayfield Fund, Meritech Capital Partners and Integral Capital Partners.

In the release, the company said that the new money will be used to add employees, develop new advertising products and expand internationally.

"The commitment from our investors speaks to their confidence in our position in the online advertising industry, as data-driven audience based advertising has invigorated the market," said CEO Jeff Hirsch in the release. "We are excited that the company will have further means to leverage our leading technology and industry relationships to aggressively extend our market presence -- both in the US and internationally."

As we pointed out in last week's report, AudienceScience (formerly known as Revenue Science and digiMine) has raised boat loads of capital in the past decade.As of four years ago, the total stood at about $70 million and I am trying to get an update figure of where things stand today.

AudienceScience -- which employs more than 100 people in offices in Bellevue, New York, London, Tokyo and Santa Barbara -- tracks the behaviors of Internet users in order to deliver more targeted ads. Its clients include Financial Times, Gannett, Jumpstart Automotive Media, New York Times Digital and Reuters.com.

By my count, the $20 million invested in AudienceScience would be one of the top 10 biggest venture rounds in the state so far this year.

Here's my updated list:

Calypso Medical: $50 million

Pathway Medical: $40 million

Integrated Diagnostics: $30 million

Smith & Tinker: $29 million

PopCap Games: $22.5 million

Telecom Transport Management: $20 million

AudienceScience: $20 million

Calistoga Pharmaceuticals: $15 million

Infinia: $14 million

NanoString: $14 million

Apptio: $14 million